Ñî¹óåú´«Ã½Ò•îl

Respiratory syncytial virus (RSV) may trigger invasive pneumococcal disease (IPD) in some children, but its role in doing so varies across pneumococcal serotypes, according to a recent study in The Journal of Infectious Diseases. The findings are based on three continuous French surveillance systems on IPD, pneumococcal carriage and RSV infections from 2008 to 2023. The analysis included children younger than 15 years old. (Soucheray, 8/19)

Low-dose hydrocortisone (LDH) improved aspects of cognition in women with virally suppressed HIV, a randomized trial showed. (Rudd, 8/18)

The FDA approved garetosmab (Pasatru) to reduce the formation of new heterotopic ossification lesions and disease flares in adults with fibrodysplasia ossificans progressiva (FOP), the agency announced on Wednesday. (Ingram, 8/19)

Harvard scientists feared ruining their oldest brain organoids. Instead, the tiny models kept developing, revealing a remarkable internal clock. (Molteni, 8/19)

Engineered probiotic bacteria were able to infiltrate pancreatic tumors, stimulate cancer-fighting immune cells, and slow tumor growth in animal studies. Even more strikingly, the treatment worked better when combined with chemotherapy, radiation, or immunotherapy. (8/19)

The extremely rare palatal fetus-in-fetu proved challenging for the medical team. (Firth, 8/17)